Market Report, "Osteoporosis Drugs Market in BRIC Nations 2015-2019", published

From: Fast Market Research, Inc.
Published: Fri Sep 25 2015

Osteoporosis, or porous bone, is a disease characterised by low bone density and structural deterioration of bone tissue, leading to fragile bones. This increases the risk of fractures. Osteoporosis mainly affects women, but can also affect men. In women, bone loss occurs very rapidly in the first few years after menopause and continues through the postmenopausal stage. Osteoporosis progresses when bone resorption occurs too quickly or when replacement occurs too slowly. Risk factors for osteoporosis that cannot be controlled include gender, age, body size (low body weight), ethnicity, and family history. Risk factors that can be controlled include sex hormones, medication use, calcium and vitamin intake, alcohol intake, and smoking.

Technavio's analysts forecast the osteoporosis drugs market in BRIC nations to grow at a CAGR of 17.43% over the period 2014-2019.

Full Report Details at

Covered in this report
This report covers the present scenario and the growth prospects of the osteoporosis drugs market in BRIC nations for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various pharmaceutical products used in the treatment of osteoporosis. Pharmaceutical products are classified as branded and generic drugs.

Technavio's report, Osteoporosis Drugs Market in BRIC Nations 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Brazil, Russia, India, and China; it also covers the landscape of the osteoporosis drugs market in BRIC nations and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.

Key countries

* Brazil
* China
* India
* Russia

Key vendors

* Amgen
* Eli Lilly
* Merck
* Novartis

Other prominent vendors

* Abiogen Pharma
* Deltanoid Pharmaceuticals
* F. Hoffmann La Roche
* GlaxoSmithKline
* Ligand Pharmaceuticals
* Pantarhei Bioscience
* Pfizer
* PhytoHealth
* Radius Health
* Zosano Pharma

Market driver

* Increase in aging population
* For a full, detailed list, view our report

Market challenge

* Multiple patent expiries
* For a full, detailed list, view our report

Market trend

* Shift toward anabolic treatments
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2019 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Global Osteoporosis Drugs Market 2015-2019
- Osteoporosis Drugs Market in the APAC Region 2015-2019
- Global Colorectal Cancer Drugs Market 2015-2019
- China Alendronate Sodium Market, 2010-2019
- Sanofi (SAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »